Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Tetanus Toxoid × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Multiple Myeloma 2 Lymphoma 2 Whooping Cough 1 Sarcoma 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumococcal Infections 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Measles 1 Lymphoma, Non-Hodgkin 1 Lipodystrophy, Congenital Generalized 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Human Papillomavirus-Related Cervical Carcinoma 1 Hodgkin Disease 1 Hepatitis B 1 HIV Infections 1 Gliosarcoma 1 Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Temozolomide 133 Bevacizumab 62 Radiotherapy 52 Magnetic Resonance Spectroscopy 51 Irinotecan 25 Carboplatin 22 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 15 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 trametinib 11 Radiosurgery 11 Cyclophosphamide 10 Topotecan 9 IL13-PE38 9 Everolimus 9 ribociclib 8 fluorodopa F 18 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8 Erlotinib Hydrochloride 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡